Previous 10 | Next 10 |
The following slide deck was published by Teleflex Incorporated in conjunction with their 2019 Q2 earnings Read more ...
Second Quarter Revenues from Continuing Operations of $652.5 million, up 7% versus Prior Year Period; up 9.6% on a Constant Currency Basis Second Quarter GAAP Diluted EPS from Continuing Operations of $1.77, Compared to ($0.06) in the Prior Year Period Second Quarter Adjusted ...
WAYNE, Pa., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of the “Pivotal Clinical Study to Evaluate the Safety and Effectiveness of the MANTA Percutaneous Vascular Closure Device.” The SAFE MANTA IDE Clinical Trial, the la...
WAYNE, Pa., July 18, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that financial results for the second quarter 2019 will be released before market open on Thursday, August 1, 2019. An investor conference call will be held at 8:00 a.m. (ET) on Thursday, A...
AngioDynamics ( ANGO ) has been a crappy stock over the long term, with a 10-year annualized return of only a bit more than 5% and a 15-year annualized return that is even worse. Over that same period, Medtronic ( MDT ) would have earned you about 12%/year, Becton, Dickinson ( BDX ) 15%,...
WAYNE, Pa., July 09, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the publication of positive results from a multi-center study reaffirming the safety and effectiveness of the minimally invasive UroLift ® System for the treatment of benign prostatic ...
Anthem, one of the leading health insurance providers is now covering Teleflex's (NYSE: TFX ) UroLift System, a minimally invasive treatment for men with benign prostatic hyperplasia (BPH). More news on: Teleflex Incorporated, Healthcare stocks news, Read more ...
WAYNE, Pa., June 26, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced that Anthem ® , one of the nation’s leading health insurance providers is now covering the UroLift ® System, a proven, minimally invasive treatment for men with benign pros...
Teleflex (NYSE: TFX ) says it will recall some lots of its Hudson RCI Sheridan endotracheal tubes used to help patients breathe, following reports of four deaths. More news on: Teleflex Incorporated, Healthcare stocks news, Read more ...
WAYNE, Pa., June 24, 2019 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), has announced a worldwide recall of certain lots of Hudson RCI ® Sheridan ® Endotracheal Tubes. The recalled products are designed for oral or nasal intubation and are indicated for airway man...
News, Short Squeeze, Breakout and More Instantly...
WAYNE, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Ringer™ Perfusion Balloon Catheter (PBC), the only commercially available Perc...
WAYNE, Pa., July 29, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it was awarded two group purchasing agreements with Premier, Inc. Effective July 1, 2024, the Premier National Hemostasis Products and SURPASS® ...
WAYNE, Pa., July 24, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the establishment of the Teleflex Center for Antimicrobial Protection (TCAP) as a strategic branch of its Vascular Access business unit led by Chuck ...